Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine

Barbara Jarząb; Józef Roskosz; Marzena Gawkowska-Suwińska; Maria Turska; Daria Handkiewicz-Junak; Zbigniew Puch; Zbigniew Wygoda; Aleksander Zajusz

Vol 3, No 2 (2000)

Brief communication

Published online: 2003-05-27

Submitted: 2012-01-23

Get Citation

Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine

Barbara Jarząb, Józef Roskosz, Marzena Gawkowska-Suwińska, Maria Turska, Daria Handkiewicz-Junak, Zbigniew Puch, Zbigniew Wygoda, Aleksander Zajusz

Nucl. Med. Rev 2000;3(2):157-160.

Vol 3, No 2 (2000)

Short communications

Published online: 2003-05-27

Submitted: 2012-01-23

Abstract

The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (DTC) is already approved, however its application in ¹³¹I therapy is still to be evaluated. We report results obtained in four patients with DTC metastatic to central skeleton, in whom 5 courses of rtTSH aided 131I therapy were administered.